Core Viewpoint - Zhejiang Dongri has corrected its Q3 2025 financial report, revealing a shift from revenue growth to a slight decline, while profits showed an upward adjustment [1][2]. Financial Adjustments - The company's Q3 revenue was adjusted from 192 million yuan (4.03% YoY growth) to 185 million yuan (-3.87% YoY decline) [1] - Total profit increased from 55.46 million yuan (8.93% YoY decline) to 60.90 million yuan (9.80% YoY growth) [1] - Net profit attributable to shareholders was revised from 43.89 million yuan (4.71% YoY decline) to 46.06 million yuan (4.94% YoY growth) [1] - The adjusted non-recurring net profit changed from 42.17 million yuan (2.39% YoY decline) to 44.34 million yuan (2.63% YoY growth) [1] - Earnings per share remained at 0.11 yuan, with a YoY change corrected from -10.00% to 10.00% [1] - The weighted average return on equity was adjusted from 1.73% to 1.83%, with a YoY decline narrowing to 0.02 percentage points [1] Business Overview - Zhejiang Dongri, established in 1997, is primarily engaged in agricultural product wholesale platform operations, covering market development, management, logistics, food production, and financial services [2] - The company aims to achieve over 900 million yuan in main business revenue by 2025, with realization dependent on multiple uncertain factors [2] - For the first three quarters, the company reported total revenue of 558 million yuan (2.66% YoY growth) and a net profit of 115 million yuan (9.13% YoY growth) [2] - The main business revenue is derived from three segments: agricultural product wholesale market operations (36.25%), fresh food distribution (33.04%), and soybean product processing (9.44%) [2] Market Positioning - The company operates agricultural product wholesale markets strategically located near highways or urban expressways, ensuring convenient transportation and effective coverage of target customers [3] - The Louqiao market cluster is positioned near major roads, serving as a transit hub for agricultural wholesalers and extending its reach to surrounding areas [3]

Core Viewpoint - The company, Shenqi Pharmaceutical, has disclosed a rectification report and an announcement regarding accounting errors, following a decision from the Shanghai Securities Regulatory Bureau due to discrepancies in its 2023 annual report [1] Financial Adjustments - The company has adopted a retrospective restatement method to adjust its 2023 financial data, reducing sales expenses from 909.41 million yuan by 44.84 million yuan to 864.57 million yuan, and credit impairment losses from 47.69 million yuan by 44.84 million yuan to 2.85 million yuan [1] - In the consolidated cash flow statement, cash received from sales was adjusted down from 2,124.00 million yuan by 44.84 million yuan to 2,079.16 million yuan, while cash received from other operating activities was increased by 44.84 million yuan to 266.39 million yuan [1] Recent Financial Performance - For the third quarter of 2025, the company reported revenue of 437 million yuan, a year-on-year decline of 3.51%, and a net profit attributable to shareholders of 17.49 million yuan, down 18.7% year-on-year [1] - The company's net profit excluding non-recurring items was 16.03 million yuan, reflecting a year-on-year decrease of 19.74%, with net cash flow from operating activities amounting to 110 million yuan [1]

Core Viewpoint - The company has issued a correction announcement regarding its financial data for the first quarter of 2025, specifically affecting the consolidated balance sheet without impacting the income statement or cash flow statement [1][2]. Summary by Sections Overview of the Correction - The correction pertains to the consolidated balance sheet of Beijing Airport Technology Park Co., Ltd. for Q1 2025, and it does not significantly affect the company's financial condition or operating results [1][2]. - The correction was approved by the company's board of directors, audit committee, and supervisory board, and does not require shareholder approval [1]. Details of the Correction - The company identified errors in reporting due to personnel oversight, affecting various accounts including other payables, total current liabilities, total liabilities, capital reserves, undistributed profits, and total equity attributable to shareholders [2][3]. - The specific adjustments include a reduction of other payables by CNY 64,764,532.55, an increase in capital reserves by CNY 63,435,591.67, and an increase in undistributed profits by CNY 1,328,940.88, resulting in a total equity increase of CNY 64,764,532.55 [3][4]. Financial Impact - The adjustments resulted in a minor decrease in the weighted average return on equity by 0.01% for Q1 2025 [3]. - The total assets after correction amounted to CNY 2,679,407,700.87, reflecting an increase of CNY 283,303,841.71 from the previous reporting [7][10]. Approval Process - The audit committee, board of directors, and supervisory board have all reviewed and approved the correction, confirming that it aligns with relevant regulations and does not harm the interests of the company or its shareholders [12][14].

Core Viewpoint - The company, Jinfu Technology (300128), has announced corrections to its previously disclosed financial data for multiple periods, including adjustments to revenue, investment income, cash flow statements, and non-recurring gains and losses, which do not affect total profit, net profit, or the balance sheet [1] Financial Data Corrections - The consolidated financial statements for 2022 show a revenue adjustment from 1.402 billion to 1.4 billion yuan [1] - Investment income was adjusted from -44.07 million to -42.4573 million yuan [1] - Non-recurring gains and losses were adjusted from 18.817 million to 19.9792 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was adjusted from -244 million to -246 million yuan [1] - For the parent company's financial statements, revenue was adjusted from 48.9685 million to 48.405 million yuan [1] - Investment income was adjusted from 61.136 million to 61.6995 million yuan [1]